Comprehensive management and classification of first branchial cleft anomalies: An International Pediatric Otolaryngology Group (IPOG) consensus statement.

Objective: First branchial cleft anomalies are rare congenital head and neck lesions. Literature pertaining to classification, work up and surgical treatment of these lesions is limited and, in some instances, contradictory. The goal of this work is to provide refinement of the classification system of these lesions and to provide guidance for clinicians to aid in the comprehensive management of children with first branchial cleft anomalies.
Materials and Methods: Delphi method survey of expert opinion under the direction of the International Pediatric Otolaryngology Group (IPOG) was conducted to generate recommendations for the definition and management of first branchial cleft anomalies. The recommendations are the result of expert consensus and critical review of the literature.
Results: Consensus recommendations include evaluation and diagnostic considerations for children with first branchial cleft anomalies as well as recommendations for surgical management. The current Work classification system was reviewed, and modifications were made to it to provide a more cogent categorization of these lesions.
Conclusion: The mission of the International Pediatric Otolaryngology Group (IPOG) is to develop expertise-based recommendations based on review of the literature for the management of pediatric otolaryngologic disorders. These consensus recommendations are aimed at improving care of children presenting with first branchial cleft anomalies. Here we present a revised classification system based on parotid gland involvement, with a focus on avoiding stratification based on germ layer, in addition to guidelines for management.
Competing Interests: Declaration of competing interest Below we have listed any relevant disclosures or conflicts of interest among the authors of our manuscript, “Comprehensive management and classification of first branchial cleft anomalies: An International Pediatric Otolaryngology Group (IPOG) consensus statement.” Daniel Chelius, MD: Leadership role and stipend as AAO-HNSF Annual Meeting Coordinator, 2021–2024. Steven Goudy, MD, MBA: Founder and Chief Medical Officer of Dr. Noze Best. Kris Jatana, MD, FACS, FAAP: Royalties (Marpac Inc.), Shareholder (Tivic Health Systems), Officer/Shareholder (Zotarix LLC, in collaboration with Grace Medical). For all remaining authors of this work, there are no conflicts of interest or financial disclosures to report.
(Copyright © 2024. Published by Elsevier B.V.)